Business Standard

Torrent Pharma Q2 profit up 27% at Rs 310 cr on robust sales, low expenses

The company had posted a net profit of Rs 244 crore for the corresponding period of the previous fiscal, Torrent Pharmaceuticals said in a filing to BSE

Torrent Pharma, Pharma

Press Trust of India New Delhi
Drug firm Torrent Pharmaceuticals on Monday reported a 27.04 per cent rise in consolidated net profit to Rs 310 crore for the quarter ended September, mainly on account of robust sales in India and reduction in expenses.
The company had posted a net profit of Rs 244 crore for the corresponding period of the previous fiscal, Torrent Pharmaceuticals said in a filing to BSE.
Consolidated revenue from operations stood at Rs 2,017 crore for the quarter under consideration. It was Rs 2,005 crore for the same period a year ago.
India revenues grew to Rs 963 crore for the quarter ended September 30, 2020, as against Rs 899 crore earlier, Torrent Pharma said.
Total expenses dipped to Rs 1,639 crore as compared to Rs 1,743 crore in the second quarter of FY20.
Shares of Torrent Pharmaceuticals closed at Rs2,654.45per scrip on BSE, down 2.92 per cent from its previous close.

(Only the headline and picture of this report may have been reworked by the Business Standard staff; the rest of the content is auto-generated from a syndicated feed.)

Don't miss the most important news and views of the day. Get them on our Telegram channel

First Published: Oct 26 2020 | 7:15 PM IST

Explore News